Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saffron Supplement in Ulcerative Colitis
NCT05715099Phase 4Unknown
- Sponsor
- Minia University
- Start
- Mar 2023
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial (6 arms), sponsored by Minia University. Primary endpoints: fecal calprotectin assessment at 8 weeks, C reactive protein assessment at 8 weeks and 2 more. Status: unknown.
Beyond the preview
Go deeper on NCT05715099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05715099.